KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia

KFSHRC Launches the First Facility for Gene and Cell Therapy Manufacturing in Saudi Arabia At Global Health Exhibition 2025 ...

Exosomes for hair loss: What is it & what does it cost?

This article was reviewed by Knox Beasley, MD. Exosomes for Hair Loss: Costs, Safety, Efficacy, & Benefits The deeper you ...

Fate Therapeutics Presents New Clinical Data at ACR Convergence 2025 Demonstrating Immune Remodeling and Durable Responses in Patients with Syste…

As of a September 25, 2025 data cut-off-date, 10 patients with treatment-refractory, moderate-to-severe Systemic Lupus ...
The Manila Times

Creative Medical Technology Holdings Issues Letter to Shareholders

Ongoing Phase II Clinical Trials, Recently Issued Patents, and AI Integration Initiatives Set the Stage for Continuing Progress in 2026 ...
Le Lézard

NLS Pharmaceutics and Kadimastem Announce Strategic Collaboration between Kadimastem and TargetGene to Advance Next-Generation Gene-Edited Cell Therapies

NLS Pharmaceutics Ltd. ("NLS"), a Swiss clinical-stage biopharmaceutical company focused on central nervous system and neurodegenerative disorders and Kadimastem Ltd. ("Kadimastem"), a clinical-stage ...

What To Know About Brain Tumour, How It Affects Patients, And Are There Early Signs To Detect It?

Unlike other organs, brain can't feel pain. Most tumours grow quietly until they become large to press on surrounding tissue.
PharmiWeb

Regenerative Medicine Market Size and Share – Future Growth Expectations

The global regenerative medicine market is poised for remarkable expansion, expected to record a compound annual growth rate (CAGR) of around 17% during the forecast period. This surge is primarily ...